EN FR menu Muyunkum south facilities © Orano Nuclear Expertise Innovation Careers Canada China USA Cominak Remediation Tricastin Melox La Hague Malvési Logistics Engineering CIME LEA Orano Innovation PME Orano Med RSE Mining News Group Finance Press Legal Notice Contact Cookies Settings

IN FR About Orano Med Orano Med's ambition is to develop a new generation of targeted cancer therapies thanks to the unique properties of lead-212 Find out more Technology Targeted alpha therapy: an effective option in the fight against cancer Find out more Pipeline Based on the unique properties of lead-212, Orano Med is developing a portfolio of therapies combining lead-212 with different biological molecules Find out more Discover Orano Med and targeted alpha therapy at 212 Pb Nos dernières actualités 21.7.2021 Orano Med inaugure l'extension du Laboratoire Maurice Tubiana et son Centre de Recherche & Développement Lire 12.11.2020 Augmentation de la capacité de production de Plomb-212 pour le développement de traitements contre le cancer Lire 4.4.2019 Orano Med étend ses capacités de production en France et aux Etats-Unis Lire Voir plus d'actualités A propos Technologie Pipeline Ressources Lien vers le site Orano Mentions légales Contact By continuing to browse, you accept the use of cookies. For more information, to manage or modify the cookie settings on your computer, read our Cookies Policy in our legal notices I accept cookies I refuse cookies